These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3592786)

  • 1. Polymorphonuclear neutrophil function in systemic sclerosis.
    Czirják L; Dankó K; Sipka S; Zeher M; Szegedi G
    Ann Rheum Dis; 1987 Apr; 46(4):302-6. PubMed ID: 3592786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective neutrophil function in myotonic dystrophy.
    Seay AR; Ziter FA; Hill HR
    J Neurol Sci; 1978 Jan; 35(1):25-30. PubMed ID: 624959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosis.
    Kovacs IB; Meyrick Thomas RH; Mackay AR; Rustin MH; Kirby JD
    Clin Sci (Lond); 1986 Mar; 70(3):257-61. PubMed ID: 3948475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of neutrophil functions by naftifine.
    Solomon BA; Lee WL; Geen SC; Suntharalingam K; Fikrig SM; Shalita AR
    Br J Dermatol; 1993 Apr; 128(4):393-8. PubMed ID: 8388234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of polymorphonuclear leukocytes from peripheral blood and exudate in surgical patients.
    Hiraoka N; Nishijima J; Murata A; Oka Y; Kitagawa K; Tanaka N; Toda H; Mori T
    Eur Surg Res; 1993; 25(4):222-32. PubMed ID: 8330639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Evidence for activated neutrophils in the pulmonary circulation.
    Zimmerman GA; Renzetti AD; Hill HR
    Am Rev Respir Dis; 1983 Mar; 127(3):290-300. PubMed ID: 6830052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of monocytes in patients with systemic sclerosis.
    Czirják L; Dankó K; Zeher M; Lukács K; Szegedi G
    Acta Med Hung; 1988; 45(1):53-61. PubMed ID: 3045745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte migration and phagocytosis in progressive systemic sclerosis.
    Spisani S; Dovigo L; Colamussi V
    Scand J Rheumatol; 1981; 10(4):299-300. PubMed ID: 7323786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leucocyte function during pregnancy.
    Björksten B; Söderström T; Damber MG; von Schoultz B; Stigbrand T
    Scand J Immunol; 1978; 8(3):257-62. PubMed ID: 151912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis.
    Minta JO; Kovacs EK; Sukenik S; Lee P
    J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients.
    van Dijk WC; Verbrugh HA; van Rijswijk RE; Vos A; Verhoef J
    Surgery; 1982 Jul; 92(1):21-9. PubMed ID: 7089865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum in stimulation of polymorphonuclear leukocyte, luminol-dependent chemiluminescence by influenza A.
    Shult PA; Dick EC; Joiner KA; Busse WW
    Am Rev Respir Dis; 1985 Feb; 131(2):267-72. PubMed ID: 3970456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.
    Harvath L; Amirault HJ; Andersen BR
    J Clin Invest; 1978 May; 61(5):1145-54. PubMed ID: 207727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan.
    Williams JD; Topley N; Alobaidi HM; Harber MJ
    Immunology; 1986 May; 58(1):117-24. PubMed ID: 3710519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of inhibitory effect of eicosapentaenoic acid on phagocytic activity and chemotaxis of human neutrophil granulocytes.
    Sipka S; Dey I; Buda C; Csongor J; Szegedi G; Farkas T
    Clin Immunol Immunopathol; 1996 Jun; 79(3):224-8. PubMed ID: 8635279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic hypoxia enhances bactericidal activities of human polymorphonuclear leuocytes.
    Wang JS; Liu HC
    Clin Sci (Lond); 2009 May; 116(11):805-17. PubMed ID: 19053944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional PMN defects in young periodontal patients].
    Zucchelli G; Parente R; Melotti C
    Dent Cadmos; 1991 Feb; 59(3):48-56. PubMed ID: 2070912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.
    Leirisalo-Repo M; Lauhio A; Repo H
    Ann Rheum Dis; 1990 Aug; 49(8):615-9. PubMed ID: 2396867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.